Gladstone NOW: The Campaign Join Us on the Journey ✕
46 - 60 of 1505 Results Clear All
Gladstone scientists have developed a thinking microscope powered by artificial intelligence.
AI Finkbeiner Lab Neurological Disease Center for Systems and Therapeutics Alzheimer’s Disease Parkinson’s Disease ALS
An innovative chromatin-shredding technique shown to destroy cancer cells carrying a prevalent mutation while keeping healthy cells intact.
News Release Research (Publication) Doudna Lab CRISPR/Gene Editing Cancer
Genetic Engineering & Biotechnology News—Gladstone Investigator Jennifer Doudna and collaborators developed a CRISPR-based strategy that selectively destroys cancer cells with p53 mutations, opening a potential new path for treating some of the deadliest cancers.
Doudna Lab CRISPR/Gene Editing
The center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.
News Release Grants Data Science and Biotechnology Infectious Disease Shipman Lab Pollard Lab Ott Lab Silas Lab AI
The prize honors scientists whose breakthroughs in brain research have high potential for patient impact.
Philanthropy Awards News Release Alzheimer’s Disease Neurological Disease Yang Lab
Gladstone scientists developed a new tool to trace how the brain clears “waste,” uncovering surprising new biology about how it keeps itself healthy.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Yang Lab
Nature—Gladstone President Deepak Srivastava comments on the strong preclinical data supporting a first-in-human gene therapy designed to stimulate heart-muscle regeneration. (Subscription required.)
Heart Failure Congenital Heart Disease
STAT—Gladstone President Deepak Srivastava offers commentary on a novel approach to heart failure that involves a stem cell-based patch to regenerate cardiac muscle.
Congenital Heart Disease Heart Failure
Health Channel—In this video, Gladstone Investigator Yadong Huang explains how repurposed drugs that are already approved by the FDA can expedite potential new treatments for Alzheimer’s disease.
San Francisco Business Times—Gladstone Investigator Barbara Engelhardt is leading menstrual-cycle research aimed at collecting biometric data from more diverse populations while carefully considering participant privacy and data security.
Engelhardt Lab Gladstone Experts
Gladstone virologist Melanie Ott explains why this rare, person-to-person hantavirus strain illustrates the need for diligent pandemic preparedness.
Infectious Disease Krogan Lab Ott Lab
Scientists find a gene essential for keeping intestinal stem cells stable, offering insight into how tissues repair themselves.
News Release Research (Publication) Yamanaka Lab Stem Cells/iPSCs
Gladstone ranks 15th among 60 institutes and centers nationally for its ability to turn discoveries into measurable health outcomes.
Institutional News News Release
A new study upends long-held view about how DNA is stored, explaining how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Aging AI
New York Times—Gladstone Investigator Shinya Yamanaka is featured for his discoveries that helped shape the field of cellular rejuvenation.
Yamanaka Lab Stem Cells/iPSCs Regenerative Medicine
